Gilenya and Long Term Effects on Relapsing Remitting MS

The clinical trial, Transform, showed that long term Gilenya treatment can maintain low disease activity in those with Relapse-Remitting MS. The results also showed relapse rates significantly lower than those using interferon- Beta therapies. Make sure and check out the article in Multiple Sclerosis News Today!